Down -26.04% in 4 Weeks, Here's Why RxSight (RXST) Looks Ripe for a TurnaroundZacks Investment Research • 07/29/24
RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 07/12/24
What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now?Zacks Investment Research • 05/28/24
Why Top-Rated Medtech RxSight Has 20/20 Vision — And Is Seeing 55% GrowthInvestors Business Daily • 05/22/24
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 05/13/24
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual MeetingGlobeNewsWire • 04/04/24
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 03/27/24
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare ConferenceGlobeNewsWire • 03/01/24
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024GlobeNewsWire • 02/14/24
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 GuidanceGlobeNewsWire • 01/07/24
RxSight, Inc. (RXST) Recently Broke Out Above the 50-Day Moving AverageZacks Investment Research • 11/15/23